Source link : https://www.newshealth.biz/health-news/sustained-benefits-with-transcon-pth-in-hypoparathyroidism/
TOPLINE: Long-term treatment with TransCon parathyroid hormone (PTH), a replacement therapy for hypoparathyroidism, demonstrates sustained efficacy and safety in patients with hypoparathyroidism over 52 weeks, with 95% of participants able to discontinue conventional therapy. METHODOLOGY: Conventional therapy for hypoparathyroidism (active vitamin D and elemental calcium) alleviates symptoms of hypocalcemia, but it does not improve insufficient […]
Author : News Health
Publish date : 2024-11-12 09:56:14
Copyright for syndicated content belongs to the linked Source.
